Published within
|«
«
|
...
|
3
|
4
|
5
|
6
|
7
|
8
|
9
|
10
|
11
|
...
|
»
»|
| Type |
Product title / description
|
Pub
|
Price |
CommentWire
|
Banco Santander-owned Abbey [ANL.L], the UK's second largest mortgage lender, is bracing itself for an expected FSA fine over its endowment mortgage complaint procedures. Although such a fine would bring the lender community more bad press, it at least embodies the welcome regulatory pressure on providers that persistently ignore mortgage endowment complaints.
Published By Datamonitor
|
12 Apr 2005 |
|
CommentWire
|
The Financial Services Authority has fined Abbey [ANL.L] a record GBP2 million for "serious compliance failings" relating to its money laundering monitoring between December 2001 and April 2003. The fine will hurt Abbey as it has invested large amounts in growing its wrap platform and the success of this proposition will depend on the company's ability to gain trust from IFAs.
Published By Datamonitor
|
10 Dec 2003 |
|
CommentWire
|
Abbey [ABBE.L], the UK's third largest mortgage lender, has raised the fee it charges on early redemption by 25%, to GBP225, and evidence suggests it is not alone among lenders in so doing. While these rate hikes are in response to higher administration costs, some lenders may be using early redemption fees to bolster margins by the back door.
Published By Datamonitor
|
04 May 2005 |
|
CommentWire
|
Reports suggest the FSA will rule that Abbey must review rejected complaints over endowment mis-selling. Such a move by the UK banking watchdog would come at the worst possible time for Abbey. Abbey's new owners Banco Santander have already faced criticism over heavy job losses: the last thing the bank needs now is a public admonishment over its complaints procedures.
Published By Datamonitor
|
17 May 2005 |
|
CommentWire
|
By cutting the payouts to its life insurance policyholders, Abbey [ABBE.L] has avoided the wrath of its investors. The move may have plugged the financial gap in the short-term but it has not solved the underlying cash flow problems faced by Abbey's life division.
Published By Datamonitor
|
14 Jul 2004 |
|
CommentWire
|
The restructuring will allow each new business to develop specific strategies tailored to their distinct markets. This is particularly important for the branded pharmaceutical segment, which is forecast to see low growth over the next five years. Datamonitor expects steady growth from the new medical products company and lower risk for stockholders, itself a primary driver behind this event.
Published By Datamonitor
|
21 Oct 2011 |
|
Expert View
|
According to media reports, pharmaceutical company Abbott Laboratories is looking to auction off its influenza vaccine business in a deal that could be worth up to $600m. Abbott's established link to the Russian flu market and its advanced cell-based technology make the business an attractive prospect for would-be buyers, which may include the likes of GlaxoSmithKline and MedImmune.
Published By Datamonitor
|
29 Jun 2010 |
|
CommentWire
|
LV= has announced that its new broker division, ABC Insurance, is scheduled to launch in June 2007. The launch will add a new brand, an additional distribution channel, and a strong management team to LV='s proposition; moving it one step closer to its ambitious aim of becoming a top five UK general insurer.
Published By Datamonitor
|
19 Apr 2007 |
|
Expert View
|
US casualwear brand Abercrombie & Fitch opened its first store outside North America on March 22 in London. The company plans to open flagship stores in other European cities, as well as in Japan, as it grows into a global brand. The question is whether it will achieve success with its typically American style or end up with Gap's core problem - being unable to adapt to different markets.
Published By Datamonitor
|
22 Mar 2007 |
|
CommentWire
|
UK asset manager Aberdeen's stock keeps plummeting, and its future looks bleak. In the eyes of many investors, the company is reaping the rewards of its ill-gotten gains from the TMT bubble. Aberdeen may end up as the compensatory head that UK investors are served on a platter - and some might view this as just deserts.
Published By Datamonitor
|
25 Oct 2002 |
|
|«
«
|
...
|
3
|
4
|
5
|
6
|
7
|
8
|
9
|
10
|
11
|
...
|
»
»|
No help is available.
Reports and briefs contain analyst driven analysis and opinion covering a specific market or issue.
Business Insight reports are an objective source of data, analysis and market insight
Insight for technology vendors into customer trends and pain points from key business decision makers.
Butler Group's thought leadership, opinion, with end user case studies and product profiles for key vendors.
Butler Group's vendor ranking and assessment model groups vendors into Outperform, Perform, and Under-perform categories.
Butler Group's thought leadership, opinion, and best practice with technology audits, product comparisons and rankings.
Opinion and market commentary from Datamonitor's industry experts.
Company profiles deliver detailed insight into how companies are organized and function with SWOT analysis.
Company reports provide detailed company evaluations.
Opinion and market commentary from Datamonitor's industry experts.
Company reports provide detailed company evaluations.
Opinion and market commentary from Datamonitor's industry experts.
Opinion and market commentary from Datamonitor's industry experts.
Track industry events, markets, products, customers, prospects, competitors and partners
Country profiles presenting easy-to-digest summaries and standardized data.
Databooks use charts and tables to provide a data-centric view of a particular market or category
Opinion and market commentary from Datamonitor's industry experts.
Comprehensive category data, including market value, volume, segmentation and share, with analysis.
Industry profiles provide standardized market data (including size & segmentation) and competitive analysis.
Market sizing and forecast data for a market or sector delivered in spreadsheet format.
Track industry events, markets, products, customers, prospects, competitors and partners
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Reports and briefs contain analyst driven analysis and opinion covering a specific market or issue.
Opinion and market commentary from Datamonitor's industry experts.
Insight for technology vendors into customer trends and pain points from key business decision makers.
Business information covering a specific market or issue.